Business Standard

Aurobindo Pharma plans to launch 50-60 products in US in FY21

On a constant currency basis, it increased by 26 per cent year-on-year to around $1.62 billion led by improvement in volumes and new product launches

Aurobindo Pharma
Premium

Aurobindo Pharma's US business posted a growth of 27 per cent year-on-year to Rs 11,484 crore in FY20.

Press Trust of India Hyderabad
Aurobindo Pharma is expected to launch 50 to 60 new products during the current year, N Govindarajan, managing director of the city-based drug maker has said.

"We are expecting to launch around 50 to 60 products this year including injectables...Out of the 50 to 60 products that we are talking about, 25 products have already been approved," he said during the latest earnings call earlier this month.

Aurobindo Pharma's US business posted a growth of 27 per cent year-on-year to Rs 11,484 crore in FY20.

On a constant currency basis, it increased by 26 per cent year-on-year to around $1.62

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jun 22 2020 | 6:08 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com